- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Hepatocellular carcinoma is the most common type of primary liver cancer in adults. It is closely linked to people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. Metabolic syndrome and non-alcoholic fatty liver disease are also increasingly recognized as risk factors for this type of cancer.
Showing the single result
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
PD-L1 |
Monoclonal Antibody-Fc engineered |
Tecentriq® |
60 mg/mL |
yes |
12 mg |
-80°C |
2022.03 |
359,00 € |
Evidentic GmbH
Am Mühlenberg 10
14476 Potsdam | Germany